糖蛋白VI是PF4/抗PF4 IgG复合物的受体并参与肝素诱导的血小板减少症中的血小板活化
该研究探究糖蛋白VI(GPVI)是否作为血小板因子4(PF4)/抗PF4 IgG复合物的受体参与肝素诱导的血小板减少症(HIT)中的血小板活化。采用血小板聚集实验、表面等离子共振和AlphaFold 3建模,发现抗GPVI抗体或ACT017可减少PF4/KKO或HIT患者血清触发的血小板聚集,PF4与GPVI结合的解离常数Kd约1 μM,而PF4/KKO复合物结合增强,解离速率降低5至17倍,Kd约30至100 nM,该结合可被肝素阻断。结论认为GPVI作为PF4/HIT抗体复合物的受体,与FcγRIIA共同参与HIT中的血小板活化。
要点
- 抗GPVI抗体或ACT017可减少PF4/KKO或HIT患者血清触发的血小板聚集。
- PF4与GPVI结合Kd约1 μM,PF4/KKO复合物结合增强,解离速率降低5至17倍,Kd约30至100 nM。
- GPVI作为PF4/HIT抗体复合物受体,与FcγRIIA共同参与HIT血小板活化。
核心结论
- GPVI作为PF4/HIT抗体复合物的受体,与FcγRIIA结合并参与HIT中的血小板活化。
研究设计与样本
- 采用血小板聚集实验、表面等离子共振和AlphaFold 3建模研究PF4、模拟HIT的单克隆抗体KKO与GPVI之间的相互作用。
主要发现
- 抗GPVI抗体或抗GPVI Fab片段ACT017减少由PF4/KKO或HIT患者血清触发的血小板聚集。
- 表面等离子共振显示PF4与GPVI结合的解离常数Kd约1 μM,PF4/KKO复合物解离速率降低5至17倍,Kd约30至100 nM,该结合可被肝素阻断。
- 非致病性抗PF4抗体RTO对上述相互作用无影响。
- AlphaFold 3建模预测阴离子GPVI表面与PF4/KKO复合物之间存在静电相互作用,PF4四聚体接触GPVI D2结构域和KKO Fab。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Platelet factor 4 (PF4) plays a central role in heparin-induced thrombocytopenia (HIT). PF4 is a positively charged tetramer that forms immune complexes with anti-PF4 immunoglobulin G, activating platelets via FcγRIIA. Despite extensive study, a platelet receptor for PF4 within these complexes has not been clearly defined. OBJECTIVE: We hypothesized that glycoprotein VI (GPVI), a collagen receptor known to interact with multiple ligands, binds PF4 and contributes to platelet activation in HIT. METHODS: We used platelet aggregation assays, surface plasmon resonance, and AlphaFold 3 modeling to investigate interactions between PF4, the HIT-mimicking monoclonal antibody KKO, and GPVI. RESULTS: Platelet aggregation triggered by PF4/KKO or HIT patient sera was reduced by anti-GPVI antibodies or the anti-GPVI Fab fragment ACT017. Surface plasmon resonance showed that PF4 binds GPVI with a dissociation constant of Kd approximately equal to 1 μM, but PF4/KKO complexes exhibited enhanced binding, with a 5 to 17-fold reduction in dissociation rate and Kd approximately equal to 30 to 100 nM. This interaction was blocked by heparin. In contrast, the nonpathogenic anti-PF4 antibody RTO had no effect. AlphaFold 3 modeling predicted electrostatic interactions between anionic GPVI surfaces and the PF4/KKO complex, with PF4 tetramers contacting both the GPVI D2 domain and KKO Fab. CONCLUSION: GPVI functions as a receptor for PF4/HIT antibody complex, engaging FcγRIIA and contributing to platelet activation in HIT.
引用
- Francischetti IMB, Dane KE, Galgo EL, et al. Glycoprotein VI is a receptor for the PF4/anti-PF4 IgG complex and contributes to platelet activation in heparin-induced thrombocytopenia (HIT). J Thromb Haemost. 2025. PMID: 40706961. doi:10.1016/j.jtha.2025.07.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。